Literature DB >> 31900285

European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer.

David Cibula1, François Planchamp2, Daniela Fischerova3, Christina Fotopoulou4, Christhardt Kohler5, Fabio Landoni6, Patrice Mathevet7, Raj Naik8, Jordi Ponce9, Francesco Raspagliesi10, Alexandros Rodolakis11, Karl Tamussino12, Cagatay Taskiran13, Ignace Vergote14, Pauline Wimberger15, Ane Gerda Zahl Eriksson16, Denis Querleu2.   

Abstract

BACKGROUND: Optimizing and ensuring the quality of surgical care is essential to improve the management and outcome of patients with cervical cancer.To develop a list of quality indicators for surgical treatment of cervical cancer that can be used to audit and improve clinical practice.
METHODS: Quality indicators were developed using a four-step evaluation process that included a systematic literature search to identify potential quality indicators, in-person meetings of an ad hoc group of international experts, an internal validation process, and external review by a large panel of European clinicians and patient representatives.
RESULTS: Fifteen structural, process, and outcome indicators were selected. Using a structured format, each quality indicator has a description specifying what the indicator is measuring. Measurability specifications are also detailed to define how the indicator will be measured in practice. Each indicator has a target which gives practitioners and health administrators a quantitative basis for improving care and organizational processes. DISCUSSION: Implementation of institutional quality assurance programs can improve quality of care, even in high-volume centers. This set of quality indicators from the European Society of Gynaecological Cancer may be a major instrument to improve the quality of surgical treatment of cervical cancer. © IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.

Entities:  

Keywords:  cervical cancer; surgical oncology; uterine cervical neoplasms

Mesh:

Year:  2020        PMID: 31900285     DOI: 10.1136/ijgc-2019-000878

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  10 in total

Review 1.  Increasing global accessibility to high-level treatments for cervical cancers.

Authors:  C Chargari; M Arbyn; A Leary; N R Abu-Rustum; P Basu; F Bray; S Chopra; R Nout; K Tanderup; A N Viswanathan; C Zacharopoulou; J C Soria; E Deutsch; S Gouy; P Morice
Journal:  Gynecol Oncol       Date:  2021-10-27       Impact factor: 5.304

Review 2.  Adjuvant therapy in early-stage cervical cancer after radical hysterectomy: are we overtreating our patients? A meta-analysis.

Authors:  Natalia R Gómez-Hidalgo; Úrsula Acosta; Tomás Gómez Rodríguez; Soraya Mico; Ramona Verges; Vicente Bebia Conesa; Melissa Bradbury; Santiago Pérez-Hoyos; Asunción Pérez-Benavente; Antonio Gil-Moreno
Journal:  Clin Transl Oncol       Date:  2022-04-19       Impact factor: 3.340

Review 3.  Minimally Invasive Surgery for Cervical Cancer in Light of the LACC Trial: What Have We Learned?

Authors:  Omar Touhami; Marie Plante
Journal:  Curr Oncol       Date:  2022-02-14       Impact factor: 3.677

4.  Treatment Outcomes of Early Carcinoma Cervix Before and After Sub-specialization.

Authors:  Vinotha Thomas; Rachel G Chandy; Ajit Sebastian; Anitha Thomas; Dhanya S Thomas; Thomas S Ram; Abraham Peedicayil
Journal:  Indian J Surg Oncol       Date:  2020-09-28

5.  Assessment of ESGO Quality Indicators in Cervical Cancer Surgery: A Real-World Study in a High-Volume Chinese Hospital.

Authors:  Yan Ding; Xuyin Zhang; Junjun Qiu; Jianfeng Zhang; Keqin Hua
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

6.  Impact of surgeon learning curve in minimally invasive radical hysterectomy on early stage cervical cancer patient survival.

Authors:  L Pedone Anchora; N Bizzarri; V Gallotta; V Chiantera; F Fanfani; A Fagotti; F Cosentino; G Vizzielli; V Carbone; G Ferrandina; G Scambia
Journal:  Facts Views Vis Obgyn       Date:  2021-09

7.  The Impact of Surgical Practice on Oncological Outcomes in Robot-Assisted Radical Hysterectomy for Early-Stage Cervical Cancer, Spanish National Registry.

Authors:  Sergi Fernandez-Gonzalez; Jordi Ponce; María Ángeles Martínez-Maestre; Marc Barahona; Natalia R Gómez-Hidalgo; Berta Díaz-Feijoo; Andrea Casajuana; Myriam Gracia; Jon Frias-Gomez; Yolanda Benavente; Laura Costas; Lola Martí; Lidia Melero; Jose Manuel Silvan; Eva Beiro; Ignacio Lobo; Jesús De la Rosa; Pluvio J Coronado; Antonio Gil-Moreno
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

8.  Surgical Outcomes of Laparoscopic Pelvic Lymph Node Debulking during Staging Aortic Lymphadenectomy in Locally Advanced Cervical Cancer: A Multicenter Study.

Authors:  Berta Díaz-Feijoó; Úrsula Acosta; Aureli Torné; Blanca Gil-Ibáñez; Alicia Hernández; Santiago Domingo; Melissa Bradbury; Antonio Gil-Moreno
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

9.  SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer.

Authors:  Nabil Manzour; Luis Chiva; Enrique Chacón; Nerea Martin-Calvo; Felix Boria; José A Minguez; Juan L Alcazar
Journal:  Ann Surg Oncol       Date:  2022-04-16       Impact factor: 4.339

10.  Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas France.

Authors:  Rita Bentahila; Elie Rassy; Samir Achkar; Florence Sacino; Stefanos Bougas; Alexis Vallard; Vincent Vinh-Hung; Johan Encaoua; Pierre Gustin; Sylvie Mengue; Patricia Pautier; Philippe Morice; Sébastien Gouy; Sophie Espenel; Eric Deutsch; Cyrus Chargari
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.